The Juvelook line-up — dose, particle and layer for all six products
Juvelook has several similarly named products, so patients often ask which one they had. This page brings the manufacturer’s product page, brochures and launch announcements into one table. No prices.
The short answer
Juvelook is one formula — PDLLA and hyaluronic acid at 85:15 — divided into six products by vial size and particle size. i and Skin are 30 mg, Juvelook 50 mg, Volume 100 100 mg, Volume and G 200 mg; mean particles are i 20, Juvelook 24, Volume and Volume 100 40, G 65 µm. The manufacturer places i, Skin and Juvelook in the dermis and Volume 100, Volume and G under the skin. Miso Clinic in Daegu (4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu; +82 53-428-2700) stocks all six.
All six at a glance
| Product | Vial | PDLLA + HA | Mean particle | Layer and use (manufacturer) |
|---|---|---|---|---|
| Juvelook i | 30 mg | 25.5 + 4.5 mg | 20 µm | Dermis; texture, sensitive skin, full face |
| Juvelook Skin | 30 mg | 25.5 + 4.5 mg | — | Dermis; wrinkles, elasticity, pores, scars (launched June 2026) |
| Juvelook | 50 mg | 42.5 + 7.5 mg | 24 µm | Dermis; skin rejuvenation (the original, 2019) |
| Juvelook Volume 100 | 100 mg | 85 + 15 mg | 40 µm | Single area: forehead, temples, cheek hollows, chin, nasolabial, marionette (Sept 2026) |
| Juvelook Volume | 200 mg | 170 + 30 mg | 40 µm | Subcutaneous; volume |
| Juvelook G | 200 mg | 170 + 30 mg | 65 µm | Subcutaneous; broad, deep areas, contouring |
What all six share
- Ratio — 85% PDLLA, 15% hyaluronic acid.
- Category — tissue-repair material, class IV medical device, single-use and sterile.
- Approved purpose — “temporary improvement of facial wrinkles in adults by injecting polylactide and hyaluronic acid under the skin for physical repair”.
- Storage — below 30 °C, do not freeze.
How they differ
- Vial size — 30, 50, 100 and 200 mg; the 30 mg and 100 mg vials are sized for one person per vial.
- Particle size — small particles spread shallowly and evenly through fine needles; large particles support broader, deeper planes. See the particle size column.
- Layer and use — dermal products for texture, fine lines and pores; subcutaneous products for volume and contour.
How to tell which product you had
By cap and box colour: in the brochure, i is green, Juvelook blue, Volume black and G gold. The box shows the vial size in mg.
We show the box and vial before treatment and, if you wish, the lot number and expiry date. Keeping this record makes it easy to decide on the next session.
Juvelook line-up FAQ
How many Juvelook products are there?
Six: i and Skin (30 mg), Juvelook (50 mg), Volume 100 (100 mg), Volume and G (200 mg).
Does the ratio differ between products?
No. All are 85% PDLLA and 15% hyaluronic acid.
Volume vs Volume 100?
Same 40 µm particle and formula; 200 mg vs 100 mg. Volume 100 suits treating one area.
Volume vs G?
Both 200 mg and subcutaneous; mean particle 40 µm for Volume and 65 µm for G.
Where can I get a Juvelook consultation in Daegu?
Miso Clinic is on the 4th floor of the Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82 53-428-2700. Weekdays 11:00–19:00, Saturdays 10:00–16:00, closed Sundays and public holidays. The clinic stocks the full Juvelook line (i, Skin, Juvelook, Volume 100, Volume and G).
Read next
- Juvelook reviewed: ingredients, line-up, research and how to choose
- Juvelook particle sizes: i, Juvelook, Volume, G
- Juvelook i: the smallest particle, for the dermis
- Juvelook Skin: one 30 mg vial for skin quality
- Juvelook Volume 100: 100 mg for one area
- Juvelook G: the largest particle, for deep, broad areas
- Juvelook product page
Product pages
Product page: Juvelook — PDLLA with hyaluronic acid
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, director of Miso Clinic, Daegu. The treatment standards and injection design set out here are the ones we use in practice.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- Manufacturer product page — juvelook.co.kr (VAIM Co., Ltd.). Juvelook I and Skin 30 mg, Juvelook 50 mg, Volume 100 100 mg, Volume and G 200 mg, all 85% PDLLA and 15% hyaluronic acid. Registered in Korea as a class IV medical device (tissue-repair material) for the temporary improvement of facial wrinkles in adults.
- Manufacturer brochures — VAIM Juvelook, Juvelook i and Juvelook G brochures (obtained by Miso Clinic, October 2026). Mean particle size i 20, Juvelook 24, Volume 40, G 65 µm; layer per product (i and Juvelook dermis, Volume and G subcutaneous); store below 30 °C, do not freeze; porous mesh-structured particles.
- Juvelook Skin launch — Rapportian, 1 June 2026. 30 mg, injected into the dermis for wrinkles, elasticity, pores and scars; one vial per person; patented porous mesh structure.
- Juvelook Volume 100 launch — Rapportian, 9 September 2026. 100 mg (85 mg PDLLA + 15 mg HA), mean particle 40 µm; forehead, temples, cheek hollows, chin contour, deep scars, nasolabial and marionette lines; one vial per person for a single area.
- VAIM announcement — Juvelook launched in 2019; two million vials produced (VAIM news).
- How Miso Clinic works — full Juvelook line in stock (confirmed by the director, 14–15 October 2026); concern, then layer, then product; start small and review after a few weeks; deep hollows shaped first with dissolvable hyaluronic acid filler; sagging addressed first with lifting; other options first under the eyes. Source of every “I” or “we” sentence in this column.
- Korean medical advertising law — Medical Service Act art. 56(2) and 27(3). No testimonials, before-and-after photos or prices appear here. Results and how long they last vary from person to person.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English